Neil Collinson

5.4k total citations · 2 hit papers
43 papers, 3.9k citations indexed

About

Neil Collinson is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Neil Collinson has authored 43 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 17 papers in Pulmonary and Respiratory Medicine and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Neil Collinson's work include Vasculitis and related conditions (17 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers) and Neuroscience and Neuropharmacology Research (11 papers). Neil Collinson is often cited by papers focused on Vasculitis and related conditions (17 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers) and Neuroscience and Neuropharmacology Research (11 papers). Neil Collinson collaborates with scholars based in United Kingdom, United States and Switzerland. Neil Collinson's co-authors include Gerard R. Dawson, John Atack, Katie Tuckwell, Micki Klearman, John H. Stone, Sophie Dimonaco, Bhaskar Dasgupta, Jürgen Rech, Sebastian Unizony and María C. Cid and has published in prestigious journals such as New England Journal of Medicine, Journal of Neuroscience and Journal of Medicinal Chemistry.

In The Last Decade

Neil Collinson

41 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trial of Tocilizumab in Giant-Cell Arteritis

2017 815 citations John H. Stone, Katie Tuckwell et al. New England Journal of Medicine profile →
Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABA_AReceptor

2002 509 citations Neil Collinson, Karen Maubach et al. Journal of Neuroscience profile →

Peers

Countries citing papers authored by Neil Collinson

Since Specialization

Citations

This map shows the geographic impact of Neil Collinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Collinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Collinson more than expected).

Fields of papers citing papers by Neil Collinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Collinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Collinson. The network helps show where Neil Collinson may publish in the future.

Co-authorship network of co-authors of Neil Collinson

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Collinson. A scholar is included among the top collaborators of Neil Collinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Collinson. Neil Collinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model 2021 ·PLoS Pathogens ·Leo Lee, Jie Zhou, (unknown), Rebecca Frise, (unknown), Keiko Baba, Shahjahan Miah, Takao Shishido, Mónica Galiano, Takashi Hashimoto, Shinya Omoto, Takeki Uehara, Edin Mifsud, Neil Collinson, (unknown), Barry Clinch, Steffen Wildum, William Barclay, Aeron C. Hurt	29
2	Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children 2020 ·The Pediatric Infectious Disease Journal ·Jeffrey P. Baker, S. Block, Balpreet Matharu, (unknown), Steffen Wildum, Sophie Dimonaco, Neil Collinson, Barry Clinch, Pedro A. Piedra	62
3	Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission 2020 ·PLoS Pathogens ·Leo Lee, Jie Zhou, Rebecca Frise, Daniel H. Goldhill, (unknown), Edin Mifsud, (unknown), Takahiro Noda, (unknown), Kenji Sato, (unknown), Takao Shishido, Takeki Uehara, Steffen Wildum, (unknown), Neil Collinson, (unknown), Barry Clinch, Aeron C. Hurt, William Barclay	31
4	Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial 2019 ·Arthritis Research & Therapy ·Vibeke Strand, Sophie Dimonaco, Katie Tuckwell, Micki Klearman, Neil Collinson, John H. Stone	32
5	Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data 2019 ·Rheumatology and Therapy ·Sara Gale, (unknown), Katie Tuckwell, Neil Collinson, John H. Stone, Khaled Sarsour, Jinglan Pei, Jennie H. Best, (unknown), Shalini Mohan	22
6	Trial of Tocilizumab in Giant-Cell Arteritis breakdown → 2017 ·New England Journal of Medicine ·John H. Stone, Katie Tuckwell, Sophie Dimonaco, Micki Klearman, Martin Aringer, Daniël Blockmans, Elisabeth Brouwer, María C. Cid, Bhaskar Dasgupta, Jürgen Rech, Carlo Salvarani, Georg Schett, Hendrik Schulze‐Koops, Robert Spiera, Sebastian Unizony, Neil Collinson	815
7	Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis 2016 ·Seminars in Arthritis and Rheumatism ·Michael S. Broder, Khaled Sarsour, Eunice Chang, Neil Collinson, Katie Tuckwell, Pavel Napalkov, Micki Klearman	78
8	Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case–control analysis 2016 ·Seminars in Arthritis and Rheumatism ·Jessica C. Wilson, Khaled Sarsour, Neil Collinson, Katie Tuckwell, David Musselman, Micki Klearman, Pavel Napalkov, Susan S. Jick, John H. Stone, Christoph Meier	81
9	Baseline data on patients enrolled in a randomized, double-masked trial of tocilizumab in giant cell arteritis 2016 ·Investigative Ophthalmology & Visual Science ·Zdenka Hašková, Katie Tuckwell, Neil Collinson, Micki Klearman, Sophie Dimonaco, John H. Stone	1
10	Development and Implementation of a Double‐Blind Corticosteroid‐Tapering Regimen for a Clinical Trial 2015 ·International Journal of Rheumatology ·Neil Collinson, Katie Tuckwell, (unknown), (unknown), Micki Klearman, John H. Stone	11
11	Substituted fused bicyclic pyrrolizinones as potent, orally bioavailable hNK1 antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Gregori J. Morriello, Sander G. Mills, (unknown), Mikhail Reibarkh, Gary G. Chicchi, Julie A. DeMartino, Marc M. Kurtz, Philip R. Davies, (unknown), Song Guo Zheng, Xinchun Tong, Emma Carlson, (unknown), F.D. Tattersall, Alan Wheeldon, Susan Boyce, Neil Collinson, N.M.J. Rupniak, Stephen Moore, Robert J. DeVita	8
12	Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR) 2010 ·Lara D. Veeken ·Andrea Rubbert‐Roth, P. P. Tak, Cristiano A. F. Zerbini, (unknown), Luis Carreño, G. Armstrong, Neil Collinson, T. Shaw, (unknown)	139
13	Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonists 2007 ·Bioorganic & Medicinal Chemistry ·Gregori J. Morriello, Robert J. DeVita, Sander G. Mills, Jonathan R. Young, Peter Lin, George A. Doss, Gary G. Chicchi, Julie A. DeMartino, Marc M. Kurtz, Kwei‐Lan Tsao, Emma Carlson, (unknown), Alan Wheeldon, Susan Boyce, Neil Collinson, N.M.J. Rupniak, Stephen Moore	24
14	α5GABA _A Receptors Mediate the Amnestic But Not Sedative-Hypnotic Effects of the General Anesthetic Etomidate 2006 ·Journal of Neuroscience ·Victor Cheng, Loren J. Martin, Erin Elliott, John H. Kim, Howard T.J. Mount, Franco A. Taverna, John Roder, John F. MacDonald, (unknown), Neil Collinson, Keith A. Wafford, Beverley A. Orser	183
15	An inverse agonist selective for α5 subunit-containing GABAA receptors improves encoding and recall but not consolidation in the Morris water maze 2006 ·Psychopharmacology ·Neil Collinson, John Atack, (unknown), Gerard R. Dawson, David Stephens	78
16	An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Gerard R. Dawson, Karen Maubach, Neil Collinson, Mark Cobain, Barry J. Everitt, Angus M. MacLeod, Hedaythul Choudhury, Louise McDonald, Gopalan V. Pillai, Wayne Rycroft, Alesha Smith, Francine Sternfeld, F.D. Tattersall, Keith A. Wafford, David S. Reynolds, Guy R. Seabrook, John Atack	207
17	Anxiogenic properties of an inverse agonist selective for α3 subunit‐containing GABA_A receptors 2005 ·British Journal of Pharmacology ·John Atack, Peter H. Hutson, Neil Collinson, George Marshall, Graham Bentley, Christopher R. Moyes, Susan M. Cook, Ian Collins, Keith A. Wafford, Ruth M. McKernan, Gerard R. Dawson	116
18	Development of Subtype Selective GABA_AModulators 2005 ·CNS Spectrums ·Gerard R. Dawson, Neil Collinson, John Atack	31
19	Selective, Orally Active γ-Aminobutyric Acid _A α5 Receptor Inverse Agonists as Cognition Enhancers 2004 ·Journal of Medicinal Chemistry ·Francine Sternfeld, Robert W. Carling, Richard A. Jelley, (unknown), Kevin J. Merchant, Kevin W. Moore, Austin J. Reeve, Leslie J. Street, Desmond O’Connor, Bindi Sohal, John Atack, Susan M. Cook, Guy R. Seabrook, Keith A. Wafford, F.D. Tattersall, Neil Collinson, Gerard R. Dawson, José L. Castro, Angus M. MacLeod	92
20	On the elevated plus-maze the anxiolytic-like effects of the 5-HT 1A agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT 1A partial agonist, buspirone, are blocked by the 5-HT 1A antagonist, WAY 100635 1997 ·Psychopharmacology ·Neil Collinson, Gerard R. Dawson	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact